Eur J Case Rep Intern Med . A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination

[tetano]

Eur J Case Rep Intern Med


. 2021 Sep 14;8(9):002707.
doi: 10.12890/2021_002797. eCollection 2021.
A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination


Yash Kripalani[SUP] 1 [/SUP], Vidyadhara Lakkappan[SUP] 1 [/SUP], Lipeeka Parulekar[SUP] 2 [/SUP], Anjum Shaikh[SUP] 1 [/SUP], Rakesh Singh[SUP] 3 [/SUP], Pradeep Vyas[SUP] 1 [/SUP]



Affiliations

• PMID: 34671572
• PMCID: PMC8523377
• DOI: 10.12890/2021_002797

Abstract

Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition.
Learning points: Guillain-Barré Syndrome (GBS) is a very rare complication after vaccination against SARS-CoV-2.The key concepts related to the understanding, management and outcomes of patients with GBS are discussed.

Keywords: AstraZeneca; ChAdOx1; Covishield; GBS; Guillain-Barré syndrome; coronavirus; pandemic; vaccine.